-+ 0.00%
-+ 0.00%
-+ 0.00%

PURPLE BIOTECH REPORTS FINAL DATA FROM PHASE 2 STUDY OF CM24 IN PANCREATIC CANCER PATIENTS AT AACR 2025 ANNUAL MEETING: IMPROVED OUTCOMES AND SIGNIFICANT EFFICACY IN BIOMARKER-ENRICHED SUBGROUPS

Reuters·04/30/2025 11:00:03

Please log in to view news